Vertex Pharmaceuticals Inc. closed 10.89% short of its 52-week high of $519.88, which the company achieved on November 8th.

Vertex Pharmaceuticals Inc. closed 9.68% short of its 52-week high of $519.88, which the company reached on November 8th.

Valued at a market cap of $117.7 billion, Vertex Pharmaceuticals Incorporated (VRTX) is a biotechnology company that ...

Review Vertex Pharmaceuticals Inc (VRTX:XNAS) stock and the current sustainability and ESG risk rating to help with your investing decisions.

Review which funds and institutions currently hold Vertex Pharmaceuticals Inc (VRTX:XNAS) stock for ownership information.